Skip to main content

Table 6 Established and potential serological markers of cardiomyopathy

From: Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis

Marker (mean ± SD)

Low LGE

High LGE

P (Mann-Whitney U)

NT-proBNP [ng/L]

125.3 ± 82.2

101.8 ± 64.1

0.18

hs-TNT [ng/L]

5.6 ± 4.2

7.4 ± 3.8

0.56

sFLT1 [ng/L]

143.7 ± 22.6

77.1 ± 21.2

0.06

PLGF [ng/mL]

36.8 ± 10.3

20.6 ± 2.2

0.02

  1. hsTNT high sensitivity cTNT, LGE late gadolinium enhancement, NT-proBNP N-terminal prohormone brain natiuretic peptide, hsTNT high sensitivity cTNT, sFLT1 soluble short form of vascular endothelial growth factor receptor-1, PLGF placental growth factor
Back to article page

Journal of Cardiovascular Magnetic Resonance

ISSN: 1532-429X

Contact us